Feed LSTA
LS
Lisata Therapeutics, Inc.
LSTA · NASDAQ
$1.18 +2.61% (+$0.03)
1M -68.19%
Market Cap $10.7M
P/E Ratio -
Div. Yield -
ROE 88.83%
Valuation
50 /100
Fair P/S 63.21x
P/B 0.72x
P/E N/A
Growth
0 /100
Declining Book val. growth 39.35%
EPS growth N/A
Rev. growth N/A
Profitability
3 /100
Weak Gross margin 14.12%
Net margin 9,756.47%
Op. margin 10,711.20%
Quality
0 /100
Poor ROIC 117.30%
ROE 88.83%
ROA 93.47%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 5.76x
Int. coverage N/A
Stability
61 /100
Moderate Beta 0.80x
EPS volatility 36.23%
Profitable years 0
Întreabă StockBot despre LSTA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David J. Mazzo
Employees
21
Headquarters
Basking Ridge
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report